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Substance P as a Mediator of Neurogenic Inflammation
after Balloon Compression Induced Spinal Cord Injury
Anna V. Leonard, Emma Thornton, and Robert Vink
Abstract
Although clinical spinal cord injury (SCI) occurs within a closed environment, most experimental models of SCI create an
open injury. Such an open environment precludes the measurement of intrathecal pressure (ITP), whose increase after SCI
has been linked to the development of greater tissue damage and functional deficits. Raised ITP may be potentiated by
edema, which we have recently shown to be associated with substance P (SP) induced neurogenic inflammation in both
traumatic brain injury and stroke. The present study investigates whether SP plays a similar role as a mediator of
neurogenic inflammation after SCI. A closed balloon compression injury was induced at T10 in New Zealand white
rabbits. Animals were thereafter assessed for blood spinal cord barrier (BSCB) permeability, edema, ITP, histological
outcome, and functional outcome from 5 h to 2 weeks post-SCI. The balloon compression model produced significant
increases in BSCB permeability, edema, and ITP along with significant functional deficits that persisted for 2 weeks.
Histological assessment demonstrated decreased SP immunoreactivity in the injured spinal cord while NK1 receptor
immunoreactivity initially increased before returning to sham levels. In addition, aquaporin 4 immunoreactivity increased
early post-SCI, implicating this water channel in the development of edema after SCI. The changes described in the
present study support a role for SP as a mediator of neurogenic inflammation after SCI.
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Introduction
Spinal cord injury (SCI) is an unexpected event that is bothdevastating and debilitating, commonly resulting in permanent
physical disability. To date, therapies have limited efficacy in
preventing or attenuating the resultant functional deficits. To de-
velop more effective therapies, it is essential that experimental
models of SCI replicate the primary injury mechanisms that occur
after human SCI—namely, an initial impact and persisting com-
pression—and then to characterize the subsequent development of
the secondary injury process. Many commonly used experimental
models of SCI involve open injury models, in which a laminectomy
is performed and the injury induced at the open site. Such an en-
vironment contrasts to the closed nature of most injuries experi-
enced in the clinical environment and ignores the effects of
persistent spinal cord compression on the secondary injury process
and resultant functional outcome.
Edema development is an important secondary injury factor
after traumatic SCI and has been well characterized both within the
injury epicenter1–6 and in the adjacent segments where a delayed
spread of edema has been demonstrated.7,8 Such edema may be
both vasogenic and cytotoxic in nature; however, it has been hy-
pothesized that the initial edema is predominantly vasogenic in
nature given that blood-spinal cord-barrier (BSCB) disruption is
also present.1,2,9–11 Increased edema represents an important sec-
ondary injury process, because it may lead to raised intrathecal
pressure (ITP).12 Such an increase in ITP can only occur in a closed
environment.
While a number of factors have been implicated in the devel-
opment of edema after central nervous system (CNS) injury, we
have recently shown that neurogenic inflammation plays an integral
role.13–19 Neurogenic inflammation is a response of perivascular,
unmyelinated afferent nerve fibers to injury or infection and is
typically characterized by vasodilation, protein extravasation, and
edema.13,14 The vascular response is facilitated by the release of
neuropeptides such as substance P (SP) and calcitonin gene related
peptide. SP is known to preferentially bind to the tachykinin NK1
receptor, activation of which results in increased barrier perme-
ability and edema development.14 Increased SP immunoreactivity
has been associated with increased blood–brain barrier (BBB)
permeability and edema development after both traumatic brain
injury (TBI)13,17 and stroke,16 while antagonism of the NK1 re-
ceptor has been shown to reduce BBB permeability and edema, and
improve functional outcome.13,17,20 Whether substance P plays a
similar role as a mediator of neurogenic inflammation after trau-
matic SCI has not yet been investigated.
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Accordingly, the current study uses a balloon compression
model of SCI to characterize changes in SP immunoreactivity,
BSCB permeability, edema, ITP, histological outcome, and func-
tional outcome from 5 h to 2 weeks post-SCI. We have used the
balloon compression model of SCI because of its closed nature and
replication of key primary injury mechanisms such as an initial
impact (rapid inflation of the balloon) and continued compression.
Further, since its original conception by Tarlov and associates,21,22
the balloon compression model has been shown to be consistent and
reproducible, with many studies demonstrating a correlation be-
tween the severity of injury and functional deficits.23
Methods
All experimental protocols were conducted according to the
guidelines established by the National Health and Medical Re-
search Council and were approved by the animal ethics committees
of the University of Adelaide and the Institute of Medical and
Veterinary Sciences.
Balloon compression model of SCI
New Zealand white rabbits (n= 88) underwent a balloon com-
pression SCI as described previously.24,25 Briefly, during the 12-h
day cycle, animals were removed from their home cages and an-
esthetized via a subcutaneous injection of a ketamine (2.5mg/kg)
and medetomidine HCl (0.25mg/kg) mixture. Once a surgical level
of anesthesia was achieved, the animal was placed onto a ther-
mostatically controlled heating pad in the prone position. Initially,
the dorsal surface of the animal’s back was shaved and a midline
incision of approximately 10 cm in length was made along the
spinous processors (approximately T11–L2). Paraspinal muscles
were retracted, and a laminectomy was performed. A balloon
catheter (ApexTM MonorailTM 4mm· 8mm, Boston Scientific)
was then inserted epidurally, within the vertebral canal, and ad-
vanced approximately 4 cm to T10 and rapidly inflated using an
inflation device (Boston Scientific) to 8 atm of pressure. The bal-
loon remained inflated for a 5-min period before being deflated and
removed. The muscular wound was then sutured closed followed
by closure of the skin with 9mm surgical clips. An additional group
of animals underwent all surgical procedures except inflation of the
balloon catheter (sham, surgery controls).
BSCB permeability
Animals were assessed for BSCB permeability at 5 h (n= 5) or
24 h (n = 4) post-SCI (or sham, n= 5) using the Evan’s Blue (EB)
dye extravasation method as described previously.14 Briefly,
30min before perfusion, EB was injected intravenously. The ani-
mals were then perfused with saline under anesthesia and the spinal
cord dissected; 10mm segments were cut. Each segment was ho-
mogenized and the absorbance of the supernatant was measured at
610 nm using a spectrophotometer. The level of extravasated EB
within each tissue sample was then determined using a previously
obtained EB standard curve and was expressed as lg/g of spinal
cord tissue.
Edema measurement
Animals were assessed for edema at 5 h (n= 4), 24 h (n= 4), or 3
days (n= 4) post-SCI (or sham, n = 5) using the wet weight/dry
weight method as described previously.14 Briefly, animals were
administered a lethal injection of pentobarbital, and the spinal cord
was removed rapidly. The spinal cord was cut into 10mm seg-
ments, and the wet weight was obtained. Spinal cord segments were
then oven dried at 100C for 48 h before the dry weight was mea-
sured. The percentage of tissue water content was then calculated
using the equation:




Animals (injured; n = 6, sham; n = 5) underwent a tracheot-
omy and the right and left femoral arteries were dissected. The
right femoral artery was cannulated and connected to a syringe
pump containing saline, which was administered at 2 mL/h
except when taking a blood sample for blood gas analysis. A
Codman MICROSENSOR intracranial pressure (ICP) probe
was inserted into the left artery to monitor blood pressure.
Immediately after balloon compression, another Codman MI-
CROSENSOR ICP probe was introduced into the intrathecal
space and extended to the injury epicenter. The laminectomy
was then sealed with bone wax. The Codman probes were
connected to an 8 channel Powerlab system (AD Instruments)
and the output was viewed live and recorded with Labchart
(AD Instruments). ITP was monitored for a 5-h period. Blood
pressure and blood gases were monitored to ensure physio-
logical parameters were maintained.
Functional outcome
Animals (n= 12) were assessed on days 3, 7, 10, and 14 post-SCI
for both sensory and motor outcome.
The sensory prick test involved applying the tip end of Dumont
#4 fine forceps to the shaved plantar surface of the hind paws.
Animals were placed into an enclosed plastic box with a wire
bottom where food was provided as a distraction. The fine forceps
were applied to each hind paw 10 times with a 30-sec interval
between each application. The response of the animal’s withdrawal
to the stimulus was graded as either; 0 = no response, 1=weak
response (slight movement of one joint of the hindlimb),
2=moderate response (extensive movement of two or more joints
of the hindlimb), or 3= normal response. A sensory score out of 30
was given to each hind paw.
A modified Tarlov score21 was used to assess motor function of
the hindlimbs during a recorded 5-min monitoring period. The
criteria were as follows: 0 = no movement; 1 =minor movement of
the hindlimb joints; 2=major movement of the hindlimb joints;
3= able to stand properly but unable to hop; 4 = able to hop, but not
properly; 5= normal movement. To assess the frequency of any
observed hindlimb movement, a forelimb to hindlimb ratio was
calculated. The number of hindlimb movements per the first 20
forward moving forelimb steps was recorded. This ratio was then
converted into a percentage.
Histological outcome
Animals (n = 34) were assessed for histological outcome using
immunohistochemical techniques. Briefly, animals were perfuse
fixed with 10% formalin at 5 h, 24 h, 3 days, or 2 weeks post-SCI.
Spinal cord tissue was then processed and cut for assessment of
morphological features (hematoxylin and eosin [H&E] stain), SP
(Santa Cruz Sc-9758; 1:2000), NK1 receptor (Advanced Target-
ing Systems #AB-N33AP; 1:4000), albumin (Cappel #0113-0341;
1:20,000), microglia (Griffonia simplicifolia – Sigma L2140;
1:200), and aquaporin 4 (AQP4) (Abcam Ab9512; 1:200). All
sections were scanned at high resolution using a Hamamatsu
Nanozoomer. Slides were then viewed using the associated pro-
prietary viewing software (NDP.view v1.1.27, Hamamatsu).
Qualitative assessments were made by a blinded assessor using a
ranking system (0 = no staining to 10 = extensive dark staining).
Alternatively, whole cross-sections were exported and assessed
using a color deconvolution method as described previously in
detail elsewhere.26
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Statistical analysis
EB extravasation, edema, ITP, plantar prick test, and color de-
convolution were analyzed using a two-way analysis of variance
(ANOVA) followed by Bonferroni post-tests. Such data was ex-
pressed as mean– standard error of the mean (SEM). Im-
munohistochemistry ranking and modified Tarlov score were
analysed using the Kruskal Wallis ANOVA followed by the Dunn
multiple comparisons test. These data were expressed as the me-
dian and interquartile ranges.
Results
BSCB permeability – EB extravasation
Sham sections of spinal cord demonstrated minimal EB ex-
travasation with only 6.93 – 1.25 lg EB/g tissue measured (Fig.
1A). At 5 h post-SCI, a significant increase in EB extravasation was
observed within the injury epicenter (15.43 – 3.04 lg EB/g tissue)
when compared with sham animals ( p< 0.001). At 24 h post-SCI, a
further increase in EB extravasation was observed within the injury
epicenter (25.75 – 10.11 lg EB/g tissue). This increase in perme-
ability was significantly greater than that observed at 5 h
( p < 0.001). At no time point post-SCI did the adjacent segments
demonstrate EB extravasation.
Edema measurement
Sham sections recorded 65.55– 2.08% spinal cord water tissue
content (Fig. 1B). At 5 h post-SCI, the percentage of spinal cord
tissue water content within the injury epicenter significantly in-
creased to 69.55– 1.74% when compared with sham animals
( p < 0.01). Further increases were recorded at both 24 h
(71.73 – 1.31%, p< 0.001) and 3 days (77.47 – 1%, p< 0.001) post-
SCI, with water content at 3 days being significantly greater than 5
and 24 h post-injury. Further, by 3 days post-SCI, a significant
increase in water content was observed within the adjacent seg-
ments when compared with sham animals (10mm ros-
tral = p< 0.05; 10mm caudal = p< 0.001).
Intrathecal pressure
Sham animals demonstrated a low ITP recording of
0.65 – 1.61mm Hg when the probe was initially inserted immedi-
ately after deflation and removal of the balloon catheter and the
laminectomy had been sealed with bone wax. Over the 5-h moni-
toring period, the ITP slightly increased and stabilized, reaching
3.75 – 1.26mm Hg by the end of monitoring (Fig. 1C). After SCI,
an immediate significant increase ( p < 0.001) in ITP was observed,
reaching 5.31 – 3.98mm Hg. ITP continued to gradually rise over
the 5-h monitoring period, reaching a maximal ITP of
7.36 – 0.79mm Hg by the end of monitoring. After injury, ITP was
significantly increased at all time points when compared with sham
( p < 0.01–0.001).
Functional outcome
Assessment of motor function confirmed that the surgical pro-
cedure did not affect motor function, with all sham animals ob-
taining a modified Tarlov score of 5 on all days post-SCI (Fig. 2A).
Injured animals demonstrated a significant decrease in hindlimb
motor function on all days post-SCI when compared with sham
animals ( p< 0.01). On days 3 and 6 post-SCI, each animal scored 0
with severe hindlimb paralysis observed. On days 10 and 14 post-
SCI, all animals scored 1 with slight movement now observed in the
hindlimbs; however, no further recovery of motor function was
observed. Increases in the frequency of hindlimb movement (Fig.
2B) were apparent by day 6 post-SCI (12.5% – 9.87%) when
compared with forelimb movement. On Day 14, this frequency
increased further, reaching 20%– 15.17%. On all days post-SCI,
however, the frequency of hindlimb movement remained signifi-
cantly worse compared with shams ( p< 0.001).
Sham animals demonstrated normal sensory function after sur-
gery (Fig. 2C), recording a score of 30 for each hindlimb on days 10
and 14 post-surgery. This result indicates that the surgical
FIG. 1. (A) Evan’s Blue (EB) extravasation was measured as an
indicator of blood-spinal cord-barrier permeability. (B) The per-
centage of spinal cord tissue water content was measured to de-
termine the extent of edema development post-SCI. (C)
Intrathecal pressure recorded at the injury epicenter in both sham
and injured animals for a 5-h monitoring period. Sham levels
indicated by the dashed line in (A) and (B). *denotes p < 0.05,
**denotes p< 0.01, ***denotes p < 0.001 when compared with
sham. # denotes p< 0.05, ## denotes p< 0.01, ### denotes
p < 0.001. SCI, spinal cord injury.
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procedure did not affect sensory function. The injured group
demonstrated a significant decrease in sensory motor function at 3
days post-SCI, with a pain withdrawal score of 11.75– 4.57 and
13 – 6.38 for the left and right hindlimbs, respectively ( p< 0.001).
Some spontaneous improvement was observed over the assessment
period, and by day 14, the pain withdrawal score was 17 – 4.96 and
16.5 – 4.43 for the left and right hindlimbs, respectively
( p < 0.001). No significant difference was observed between the
left and right hindlimbs, indicating that a correctly placed central
injury had occurred.
Morphological features – H&E staining
H&E staining was used to assess the general morphological
features after balloon compression induced SCI (Fig. 3). At 5 h
post-SCI, severe hemorrhage was present within the injury epi-
center only, predominantly within the gray matter, with substantial
tissue disruption apparent. By 24 h post-SCI, severe diffuse hem-
orrhage was still apparent within the injury epicenter, and greater
loss of tissue architecture was observed. Hemorrhage had also
spread to the adjacent segments by this time. By 3 days post-SCI,
diffuse hemorrhage was reduced within the injury epicenter, while
localied hemorrhage was still seen within the adjacent segments. At
2 weeks post-SCI, extensive tissue loss was evident with cavity
formation and minimal white matter sparing. The adjacent seg-
ments also demonstrated loss of tissue, centered within the gray
matter and radiating outward.
SP immunoreactivity
Two specific regions of SP immunoreactivity were assessed—
namely, the dorsal horn region where SP is known to be stored, and
the perivascular region to determine if SP was associated with
BSCBpermeability after SCI (Fig. 4). Shamanimals demonstrated a
moderate level of SP immunoreactivity (median ranking= 6) within
the gray matter with predominance in lamina I and II of the dorsal
horn. At 5 h post-SCI, a significant decrease (median ranking = 2)
was observedwithin the injury epicenterwhen comparedwith sham.
The adjacent segments also demonstrated reduced SP immunore-
activity,with both 10mmcaudal and rostral significantly decreasing
to a median of 4. Similarly, at 30mm caudal and rostral to the injury
epicenter, a slight decreasewas observed (median ranking = 5 and 4,
respectively). SP immunoreactivity was maximally decreased
within the injury epicenter by 24 h post-SCI, with a median ranking
of 0 ( p< 0.001). Thereafter, SP immunoreacitivity remained absent
at both 3 days and 2weeks post-SCI. SP loss extended along the cord
and was observed out to 30mm caudal and rostral.
Perivascular SP immunoreactivity was assessed within the gray
matter of the spinal cord, although the injury epicenter could not be
examined because of severe tissue disruption. Sham animals
demonstrated moderate SP intensity with a median ranking of 6. At
5 h post-SCI, only a slight decrease was observed within the adja-
cent segments. At 24 h post-SCI, a further reduction in both the
caudal and rostral directions was observed, with rostral segments
recording a slightly greater decrease (median = 4) compared with
caudal segments (median= 5). By 3 days post-SCI, all adjacent
segments had reduced SP immunoreactivity recording a median
ranking of 4. By 2 weeks post-SCI, rostral segments had returned
to sham levels, while the caudal segments still remained slightly
below sham levels.
NK1 immunoreactivity
Two regions were assessed for NK1 receptor immunoreactivity—
namely, the gray matter and the perivascular region within the
white matter (Fig. 5). Sham sections demonstrated moderate dif-
fuse staining within the gray matter with intense staining observed
within the dorsal horn. At 5 and 24 h post-SCI, a significant increase
within the injury epicenter to a median ranking of 9 was observed
throughout the entire cross-sections ( p< 0.001). At this time, a
slight increase in the proximal adjacent segments was observed
while the more distal adjacent segments showed reduced immu-
noreactivity. By 3 days post-SCI, diffuse immunoreactivity was
apparent, although no longer significantly different to shams. All
adjacent segments demonstrated reduced immunoreactivity when
compared with shams, with 30mm rostral obtaining a median
ranking of 5. By 2weeks post-SCI, a significant loss of tissue within
FIG. 2. Motor and sensory outcome after balloon compression
spinal cord injury (SCI). (A) Motor function was assessed using
the modified Tarlov score. (B) The frequency of observed hin-
dlimb movement was also assessed, and while an increase in
frequency was seen by day 14, this remained significantly reduced
when compared with sham animals. (C) Sensory function deficits
were assessed using the plantar prick test after injury in both the
left and right hindlimbs. **denotes p < 0.01, ***denotes p< 0.001
when compared with sham.
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the injury epicenter meant no analysis of the gray matter region
could be undertaken. The adjacent segments, however, demon-
strated a significant decrease in NK1 immunoreactivity with both
proximal adjacent segments obtaining a median ranking of 4
(rostral = p< 0.01, caudal p< 0.001).
Within the perivascular region, sham sections demonstrated
faint NK1 receptor immunoreactivity with a median ranking of 4.
At 5 h post-SCI, there was only a slight increase in NK1 immu-
noreactivity seen within any section. By 24 h post-SCI, a marked
increase in NK1 receptor immunoreactivity was observed in all
adjacent segments apart from 30mm caudal, which demonstrated
decreased immunoreactivity to a median ranking of 3. By day 3
post-SCI, however, NK1 immunoreactivity in this section had re-
turned to above sham levels. The 10mm caudal was also increased,
whereas both rostral segments had returned to sham levels. By 2
weeks post-SCI, all adjacent segments were comparable to sham
levels except for 30mm caudal, which remained increased with a
median ranking of 6. Note that the injury epicenter of injured an-
imals was not assessable because of tissue disruption.
Albumin immunoreactivity
Sham sections demonstrated minimal albumin immunoreactiv-
ity with a DABwt% by color deconvolution of 4.7 – 0.42 (Fig. 6).
At 5 h post-SCI, a significant increase was observed within the
injury epicenter (22.09 – 1.25DABwt%; p< 0.001) and proximal
adjacent segments (10mm rostral= 7.72 – 1.53DABwt%, p < 0.05;
10mm caudal = 9.58 – 3.93DABwt%, p< 0.001). At 24 h post-SCI,
albumin immunoreactivity was maximal within the injury epicen-
ter (24.64 – 2.77DABwt%; p< 0.001) and proximal adjacent seg-
ments (DABwt%= 10.68– 1.99 and 11.33 – 3.08, respectively;
p < 0.001). At 3 days post-SCI, albumin immunoreactivity de-
creased within the injury epicenter, although remained significantly
greater than sham levels (DABwt% = 13.09 – 1.79; p < 0.001). At
this time, 10mm caudal remained significantly above sham levels
(DABwt% = 8.73 – 3.13; p < 0.001); however, 10mm rostral be-
came comparable to sham (DABwt% = 6.76 – 1.03). At 2 weeks
post-SCI, all adjacent segments of spinal cord remained compa-
rable to sham, while the injury epicenter remained significantly
elevated (DABwt% = 9.05 – 2.43; p< 0.001).
Microglial immunoreactivity (ISOB4)
Within the spinal cord white matter, sham sections demonstrated
small numbers of resting microglia with long fine processes (Fig.
7). At 24 h post-SCI, many small round cells were seen and are
indicative of phagocytic microglia. Further, increased immunore-
activity was also apparent within the adjacent segments at this time.
By 3 days and 2 weeks post-SCI, marked tissue loss was observed
within the injury epicenter, and florid microglia awee present
within the white matter, becoming amoeboid in shape by 2 weeks.
The adjacent segments of spinal cord also demonstrated a gradual
increase in microglia over time, with the greatest immunoreactivity
observed at 2 weeks post-SCI.
FIG. 3. Hematoxylin and eosin staining demonstrates the morphological changes in both the injury epicenter and adjacent injury from
5 h to 2 weeks post-SCI. Cross-section scale bar = 1mm; high magnification scale bar = 100lm. Color image is available online at
www.liebertpub.com/neu
1816 LEONARD ET AL
Within the gray matter, sham sections of spinal cord dem-
onstrated a small amount of resting microglial immunoreactivity
with long fine processes. At 5 and 24 h post-SCI, increased small
round cells could be seen within the injury epicenter, which are
likely infiltrating phagocytic microglia. The adjacent segments
demonstrated an increase in microglial immunoreactivity, par-
ticularly surrounding blood vessels. By 3 days post-SCI, greater
tissue loss was observed within the injury epicenter, with many
round phagocytic microglia present. The adjacent segments
demonstrated increasing numbers of activated microglia that
appeared ramified in nature. By 2 weeks post-SCI, increased
tissue loss was observed within the injury epicenter, with larger
phagocytic cells noted. The adjacent segments demonstrated
increased microglial activity, with many fully ramified and
amoeboid in appearance.
AQP4 immunoreactivity
Two specific regions were assessed for AQP4 immunoreactivi-
ty—namely, the perivascular region and the central canal region
(Fig. 8). At 5 h post-SCI, increased AQP4 immunoreactivity was
observed in all adjacent segments of the spinal cord. The injury
epicenter was too disrupted to analyze the vasculature of the gray
matter. By 24 h post-SCI, a further increase in AQP4 immunore-
activity was seen within the caudal adjacent segments, reaching a
median ranking of 6. The rostral segments remained elevated above
FIG. 4. Assessment of substance P (SP) immunoreactivity within the dorsal horn and perivascular region after balloon compression
spinal cord injury. (A) Ranking of SP immunoreactivity within the dorsal horn region of the spinal cord demonstrated a marked decrease
within the injury epicenter at all time points post-injury (A, C). Ranking of SP immunoreactivity within the perivascular region (B, D)
demonstrated a moderate decrease after injury. (E) Higher magnification images of SP within the dorsal horn region (scale bar = 200
lm). # denotes p< 0.05, ## denotes p < 0.01, ### denotes p< 0.001 when compared with sham (indicated by the dashed line). Scale
bar = 1mm (C), 25 lm (D). Color image is available online at www.liebertpub.com/neu
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sham levels, with a median of 5. By 3 days post-SCI, the caudal
segments approached sham levels, with a median ranking of 4. By 2
weeks post-SCI, a significant decrease to a median of 1 was ob-
served at 10mm caudal. In addition, 30mm caudal and 10mm
rostral also demonstrated reduced AQP4 immunoreactivity while
30mm rostral remained comparable to sham levels.
The central canal region demonstrated faint AQP4 immunore-
activity within the ependymal cells of sham sections with a median
ranking of 3. At 5 h post-SCI, a slight increase was observed at
10mm rostral to a median of 4.5, while 30mm rostral and caudal
demonstrated a small increase to a median of 4. At 24 h post-SCI,
further increases were observed with 30mm rostral ( p < 0.01) and
10mm caudal obtaining a median ranking of 6, while 10mm rostral
and 30mm caudal had a median ranking of 5. By 3 days post-SCI,
all adjacent segments remained elevated above sham, with a me-
dian ranking of 5. By 2 weeks post-SCI, AQP4 immunoreactivity
had decreased to near sham levels.
Discussion
The balloon compression model of SCI was first described by
Tarlov and Klinger21 in dogs, and later adapted to cats,27 rats,24 and
primates.28 Such studies have demonstrated that the severity of the
balloon compression directly correlates to lesion size and behavioral
deficits. This model has since been described in rabbits,29 although
characterization has not been extensive. In the current study, balloon
compression SCI produced significant motor deficits with minimal
recovery observed over the 2-week assessment period. While this
represents the severe end of the neurological deficit scale, it is an
ideal injury severity for assessment of therapeutic interventions,
because any observed improvements can be attributed to the inter-
vention as opposed to spontaneous recovery. Frequency of hindlimb
movement was additionally measured to more accurately assess the
extent of functional recovery. Frequency of hindlimb movement
increased from day 10 to day 14 post-SCI, despite no improvement in
the Tarlov score. As such, frequency of hindlimb movement repre-
sents an important additional outcome measure of functional re-
covery that should be examined in conjunction with the modified
Tarlov score to provide a more accurate assessment.
During assessment of sensory function, it was noted that the Von
Frey hair test and Hargreaves heat test, commonly used in both rat
and mouse models of SCI,30 did not elicit a response in sham
animals. As such, the plantar prick test was used. This test showed a
significant loss in sensory function after SCI with minimal im-
provement over the 2-week assessment period. No significant dif-
ference was seen between the left and right hindlimbs, indicating a
consistent central placement of the balloon catheter, which was
easily reproducible. The significant reduction in motor function
FIG. 5. Assessment of NK1 receptor immunoreactivity after balloon compression spinal cord injury (SCI). NK1 receptor immuno-
reactivity initially increased within the gray matter of the injury epicenter and proximal adjacent segments (A, C); however by 3 days
post-SCI, a reduction was observed that became significant by 2 weeks. Perivascular NK1 receptor immunoreactivity (B, D) demon-
strated an initial increase within the proximal adjacent segments before returning to sham levels. # denotes p< 0.05, ## denotes p< 0.01,
### denotes p< 0.001 when compared with sham (indicated by the dashed line). Scale bar = 1mm (C), 50lm (D). Color image is
available online at www.liebertpub.com/neu
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observed may have impaired the ability of animals to withdraw the
hindlimb. Sudden changes in behavior, such as ceasing eating or
looking toward the hindlimb, however, were not observed when no
response was elicited. Overall, the balloon compression model
produced consistent motor and sensory deficits with minimal
spontaneous recovery by 2 weeks post-injury.
The observed loss in neurological function after the balloon
compression model of SCI can be attributed to the pathological
features apparent after histological examination. Severe hemor-
rhage was observed early post-SCI, extending into the adjacent
segments, with cystic cavitation apparent by 2 weeks post-SCI.
Such pathological features have previously been described in many
studies using the balloon compression model24 and other experi-
mental models of SCI such as the weight drop31 and clip com-
pression.32 Further, the observed pathological features are similar
to those described after human SCI.33
Microglia have also been implicated in contributing to further
cell death after SCI. Indeed, numerous in vitro studies have dem-
onstrated that microglia release factors that promote cell death such
as glutamate,34 tumor necrosis factora,34 nitric oxide,35 interleukin-
1b,36 and reactive oxygen species.37 Our results demonstrate early
increases in microglial numbers predominantly in the penumbra of
the injury epicenter. Previous studies have similarly demonstrated
that microglia populations proliferate aafter SCI.38 The early in-
creased microglial population and phagocytic appearance by 2
weeks post-SCI correlates to the loss of neuronal cells by this time,
thus implicating a role for microglia in contributing to secondary
cell death after balloon compression SCI.
Importantly, this study assessed the development of neurogenic
inflammation after traumatic SCI. It has now been well documented
that SP mediates the development of neurogenic inflammation after
both TBI and stroke.13,15–17,20 Indeed, blockade of SP through
FIG. 6. Albumin immunoreactivity after balloon compression SCI. Assessment of albumin immunoreactivity using color deconvolution (A)
demonstrated a significant increase at all time points post-injury within the injury epicenter (B). Further, significant increases were observed
10mm rostral and caudal at both 5 and 24h post-SCI. ** denotes p<0.01, *** denotes p<0.001 compared with sham (indicated by the
dashed line). ### denotes p<0.001 between indicated groups. Scale bar=1mm. Color image is available online at www.liebertpub.com/neu
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FIG. 7. Microglial immunoreactivity after balloon compression spinal cord injury (SCI). Representative images of microglial types
observed were: (A) resting microglia with fine long processes (arrows); (B) small round phagocytic cells present within areas of severe
hemorrhage; (C) activated microglia with short ramified processes; (D) fully activated microglia with very short ramified processes and
amoeboid shape suggestive of phagocytic activity. Within the white matter (E), increased microglia are present within the injury
epicenter and adjacent segments post-injury. Within the gray matter (F), increased small round microglia can be seen within the injury
epicenter after injury. The adjacent segments demonstrate ramified microglia by 3 days post-SCI, which appear fully ramified by
2 weeks post-SCI. Scale bar = 200 lm (E), 50 lm (F). Color image is available online at www.liebertpub.com/neu
FIG. 8. AQP4 immunoreactivity after balloon compression SCI. AQP4 immunoreactivity within the perivascular (A, C) and central
canal region (B, D) of the spinal cord post-injury. Note that images are within the immediately adjacent segments, because the injury
epicenter was severely disrupted. Scale bar = 25lm (C, D). Color image is available online at www.liebertpub.com/neu
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inhibition of the NK1 receptor resulted in reduced barrier perme-
ability and edema, and improved functional outcome. Reduced SP
immunoreactivity observed within the current study may be largely
from severe tissue disruption. Nonetheless, intact spinal cord ad-
jacent to the injury site exhibited declines in SP immunoreactivity,
maximal at 3 days post-injury. Similar results have been reported
after a weight drop model, with maximal SP decreases found at 1
week post-injury.39 In addition, after a transectionmodel of SCI, SP
decreased within the injury epicenter, although increased caudal to
the lesion site.40 In contrast, our own results show that perivascular
SP was comparable to sham levels rostral to the lesion site by 2
weeks post-SCI while caudal segments demonstrated reduced SP.
Taken together, these results demonstrate the varying response of
SP to injury induced by different models. Indeed, a model of
transient spinal cord ischemia in the rabbit resulted in no change in
SP expression,41 emphasizing the requirement of mechanical
trauma to induced alterations in SP expression after injury.
Our own results suggest that SP is released from the dorsal horn
stores after injury as indicated by the gradual depletion of SP over
time. Interestingly, the perivascular immunoreactivity demon-
strated a decline in SP fter injury, which differs from previous
investigations after TBI and stroke where an increase was ob-
served.13,16,17 Sharma and colleagues40 demonstrated increased SP
at 1–2 h post-SCI within the dorsal horn, suggesting an earlier time
point may be needed to observe such an increase. In addition, the
binding of SP to the NK1 receptor causes internalization42 and thus
may contribute to the observed reduction in perivascular immu-
noreactivity.
The localization of the NK1 receptor in the spinal cord has been
extensively studied, with the highest expression found within the
dorsal horn, intermediolateral cell column, and lamina X.43 The
current study is the first to assess the response of the NK1 receptor
after balloon compression. Consistent with previous studies, our
results demonstrate high NK1 immunoreactivity within the dorsal
horn region of the gray matter. After injury, the initial increase in
NK1 immunoreactivity may have been in response to the release of
SP, resulting in an up-regulation of its receptor. Indeed, after a
transection model of SCI, an up-regulation of both the NK1 re-
ceptor44 and SP40 have been reported below the lesion level. After
binding and activation of the receptor, internalization of both the
receptor and ligand occurs,42 thus potentially causing the later re-
duction in NK1 receptor immunoreactivity. Taken together, both
the changes in SP and NK1 receptor immunoreactivity support the
development of SP mediated neurogenic inflammation after SCI.
The process of neurogenic inflammation is characterized by va-
sodilation, plasma protein extravasation, and edema.45 Recent
studies after both TBI and stroke have demonstrated increased SP
immunoreactivity that is associated with BBB disruption, vasogenic
edema, andworsened neurological function.13,16,17 The current study
demonstrated significantly increased BSCB permeability at 5 and
24 h post-injury as determined by EB extravasation and albumin
immunoreactivity. Such results are consistent with previous studies
after weight drop,46 clip compression,47 transection,48 and forceps
compression49 models of SCI. Increased barrier permeability early
post-injury is likely from mechanical disruption given the severe
hemorrhage observed. Increased BSCB was observed, however,
within the intact adjacent segments, indicating a spread of barrier
disruption in a rostrocaudal direction. Such results are consistent
with previous experiments where BSCB permeability was apparent
within spinal segments beyond the injury site.10
Our own study demonstrated that albumin immunoreactivity
was confined to the injury epicenter by 2 weeks post-injury, im-
plicating restoration of the barrier within the adjacent segments.
While these results support previous investigations in which BSCB
permeability was gradually restored over time,50 considerable de-
bate remains over the timing of BSCB restoration. Some studies
have proposed that a second phase of BSCB permeability transpires
after injury as early as 3 days post-SCI.51 In comparison, Popovich
and colleagues52 have demonstrated that a second phase of BSCB
permeability occurs later at 28 days after injury, presumably be-
cause of revascularization. Given the acute assessment period in the
current study, however, no further alterations in BSCB perme-
ability were observed.
Increased BSCB permeability leads to the development of va-
sogenic edema, which has been well characterized after severe SCI,
initially within the epicenter53 followed by delayed spread to the
adjacent segments.7,8 Within the current study, increased edema
was limited to the injury epicenter at 5 and 24 h post-SCI. At 3 days
post-SCI, however, a greater increase was observed within the
epicenter, with rostrocaudal spread into the uninjured adjacent
segments. Such changes have previously been described7 and are
thought to be from ultrafiltration rather than exudation that occurs
in vasogenic edema. Our own results support this theory, because
the rostrocaudal spread of edema was associated with minimal
extravasation of albumin, suggesting that such edema was not va-
sogenic in nature.
An alternate concept of edema development after SCI implicates
the involvement of the water channel protein, AQP4. In a cold
lesion brain injury54 and contusion SCI55 model, AQP4-null mice
demonstrated increased edema development and worsened neuro-
logical outcome. Such results allude to a protective role of AQP4 in
facilitating the removal of excess water. In contrast, after a forceps
compression model, AQP4 null mice demonstrated reduced edema
and improved neurological function,12 thus implicating a role for
AQP4 in facilitating water entry into the spinal cord tissue. Up-
regulation of AQP4, however, has been associated with reduced
edema development in both contusion2 and clip compression
models,56 thus supporting a role for AQP4 in water clearance after
SCI. The current study demonstrated an initial increase in AQP4
immunoreactivity as far as 30mm from the injury epicenter and
suggests it may be responsible for the increased edema develop-
ment within the adjacent segments. Alternatively, increased AQP4
may be compensatory to facilitate water clearance. Modulation
of AQP4 through application of either antagonists or agonists is
needed to better elucidate the role of AQP4 in edema development
after SCI.
The development of edema after SCI may result in a detrimental
increase in ITP, subsequently reducing blood perfusion and con-
tributing to further tissue damage.1 The extent of ITP attributed
damage is debated, given that the vertebral canal provides some
space to accommodate edematous expansion.57 The current study,
however, certainly demonstrates increased ITP after balloon
compression SCI. The immediate ITP increase was likely caused by
an expansion of volume because of the severe hemorrhage ob-
served. Increased ITP was also apparent over time, however, which
given the increase in edema at 5 h, may be because of such edema
development. Previous studies have similarly demonstrated in-
creases in ITP after SCI that were associated with reduced blood
flow and increased tissue damage.12 Further, immediate cere-
brospinalfluid drainage to reduce raised ITP resulted in signifi-
cantly smaller areas of tissue damage 4 weeks after a contusion
injury.58 Similarly, Saadoun and colleagues12 demonstrated that
AQP4 deficient mice exhibited reduced edema and spinal cord
pressure when compared with wildtype mice. As such, ITP
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contributes to greater tissue damage and functional deficits post-
SCI and subsequently may represent an important target for future
therapeutic interventions.
Given the significant contribution of ITP to the continued de-
velopment of injury after SCI, the use of an injury model that
replicates the closed environment of a clinical injury is vital.
Moreover, Batchelor and coworkers59 demonstrated that local rises
in intracanal pressure were a determinant for poor neurological
outcome and greater tissue injury, confirming ITP as an important
injury mechanism in which current research is limited. The current
study has demonstrated that the balloon compression model pro-
duces increases in ITP that may otherwise be absent in open injury
models. Further, the balloon compression model replicates im-
portant primary injury mechanisms such as an initial impact fol-
lowed by continued compression, which are present in human SCI.
These differences in injury processes and environment may con-
tribute to the novel findings in this study.
Conclusion
The current study has demonstrated that the balloon compres-
sion model replicates many facets of human SCI while replicating
the closed environment of human injury. As such, the balloon
compression model of SCI represents an important injury model for
future use within the SCI field. Further, these results implicate the
AQP4 water channel protein in the development of edema after
injury. The changes described in the present study were associated
with alterations in the immunoreactivity of SP and the NK1 re-
ceptor, thus suggesting a role for SP as a mediator of neurogenic
inflammation after SCI. SP may thus be a potential therapeutic
target to inhibit neurogenic inflammation after injury.
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